Should I - Buy Titan Medical Stock

Current data for the transition entity shows significant volatility:

The original Titan Medical focused on the . However, after struggling with funding and failing to find a buyer, the company halted development of that robot in 2023. By late 2024, Titan Medical entered into a reverse take-over (RTO) agreement with Conavi Medical Inc. .

Most recent quotes for related tickers range from $0.28 to $0.40 (USD/CAD) as of late April 2026. should i buy titan medical stock

This is essentially a penny stock subject to extreme price swings. Industry Interest

The "Titan" you see today is likely the "Resulting Issuer" known as Conavi Medical Corp (CNVI.V), which focuses on image-guided technologies for minimally invasive heart procedures rather than surgical robotics. 2. Listing Status and Liquidity Current data for the transition entity shows significant

Deciding whether to buy stock in requires looking at a company that has undergone massive structural changes over the last few years. As of early 2026, the short answer is that the original "Titan Medical" (TMDI) essentially no longer exists as an independent surgical robotics company following a reverse take-over and a delisting from major exchanges . 1. The Core Business Has Shifted

If you find a ticker symbol for Titan Medical today, it is likely trading on the TSX Venture Exchange (under the new Conavi identity) or on the OTC (Over-The-Counter) markets under the ticker TMDIF . OTC stocks often have low "liquidity," meaning it can be hard to buy or sell large amounts of shares without moving the price significantly. 3. Financial Performance Industry Interest The "Titan" you see today is

If you wanted , this is no longer the right play. If you like Cardiovascular Imaging , the new Conavi entity might interest you. Market Status